DF/HCC Calendar
|
||||||||||||||||||||||||||||||||||||||
|
Thyme 1.3
© 2006 eXtrovert Software LLC. All rights reserved.
Please join us for a special session on February 11, 2010 from 5-7pm EDT in NRB Room 350 at Harvard Medical School or via LIVE webcast for:
Hormonal Therapy and Relevant Trials in LAM:
Experts Weigh-InSergio Harari, MD, Ospedale San Giuseppe,Milan - Italy
Joel Moss, MD, PhD, NIH-NHLBI
Steven Come, MD, Harvard Medical School,
Beth Israel Deaconess Medical Center,
Dana Farber Cancer Center Breast Cancer SPORE
The role that hormones play in driving disease onset or progression in Lymphangioleiomyomatosis (LAM) is unclear and yet, LAM is believed to be more sex-specific than breast cancer. This, along with other clues, leads us to again consider the role of hormonal modulation in potentially stopping disease progression and, what feasible and ideal trials in this area will ideally look like. Please join us as an active participant in this dialogue as we consider evidence and critical next steps.
We welcome your advanced submission of questions for our speakers. Please email those to: LAMTSC@LAMTreatmentAlliance.org by 5pm EDT on February 10, 2010. You may also participate in live Q & A on-site or via webcast.
Presentation will be followed by facilitated Q & A, light dinner and informal networking. We encourage broad circulation of this announcement to colleagues across the basic science and clinical areas.
This and all upcoming sessions will be streamed live on the Internet with password protection. To tune-in remotely for this session, please click here to request site password. Password requests must be submitted no later than 12:00pm EDT on February 11, 2010.
*See below for dates/topics/ speakers for upcoming 2010 seminars!
SPEAKERS:
Sergio Harari, MD received his medical degree from the University of Milan, Italy in 1985. His clinical training focused on pulmonology, chemotherapy and intensive care, and he held fellowships in both France and the United States in addition to his home country of Italy. His is currently the Director of the Respiratory Unit at ospedale San Giuseppe in Milan, Italy. In that capacity, Dr. Harari sees a large cohord of LAM patients, is an active member of the LAM community, and has been involved in conducting clinical research relevant to this session.
Joel Moss, MD, PhD is Deputy Chief of the Translationso Medicine Branch, National Heart, Lungh, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland. Subjects of his research include lymphangioleiomyomatosis (LAM), with emphasis on role of the LAM cell and susceptibility/modifier genes on disease progression.
Steven Come, MD is Associate Professor, Department of Medicine, Harvard Medical School; Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute; Medical Director, Breast Cancer Program, Beth Israel Deaconess Medical Center.
MEETING DATE/TIME: Thursday, February 11, 2010, 5:00-7:00 EDT
LOCATION: New Research Building (NRB), Harvard Medical School, 77 Avenue Louis Pasteur, Room 350, Boston, MA 02115 USA
PARKING: Free parking in the lot below the NRB has been graciously donated by the Department of Genetics, Harvard Medical School. Please request parking by 10am EDT on February 11th, 2010.
To attend, please RSVP and indicate if you need parking by clicking HERE.
**Please note that a valid form of ID is now required to gain access past the NRB Security Desk**
Thank you for your ongoing interest and strong participation! Again, we appreciate your help in circulating this announcement to relevant researchers, labs and clinicians. We look forward to seeing you or hearing from you via chat online on February 11th!
PAST MEETINGS: Click here to access information or videos related to past meetings.
UPCOMING 2010 SEMINAR SERIES MEETINGS:
March 4, 2010: LAM Treatment Alliance Poster Session Winners Present leading-edge works-in-progress!
April 1, 2010: Uterine Leiomyoma and LAM: Unlocking Answers - Cynthia Morton, PhD, Brigham and Women's Hospital, Cheryl Walker, PhD, The University of Texas MD Anderson Cancer Center, and Jonathan Fletcher, MD, Brigham and Women's Hospital
Stay tuned for more news!
Best regards,
David Kwiatkowski, MD, PhD and Amy Farber, PhD
Epidemiology Seminar Series
Wednesday, February 10, 2010
12:30 – 1:20 pm
Norman F. Boyd, MD, DSc, FRCPC.
Senior Scientist, Campbell Family Institute for Breast Cancer Research,
Ontario Cancer Institute, University Health Network.
Professor of Medicine, University of Toronto.
“Breast tissue composition and susceptibility to breast cancer"
Kresge 502
Harvard School of Public Health
BWH Department of Radiology: SOSMAN LECTURE
Oncologic Imaging in the Era of Personalized Medicine
Date: Tuesday, February 9, 2010
Time: 12:15pm to 1:15pm
Local: Bornstein Amphitheater (Main Pike)
Speaker: Hedvig Hricak, MD
Chair, Department of Radiology
Memorial Sloan-Kettering Cancer Institute New York, NY
Date: Tuesday, February 9, 2010
Time: 12:15pm to 1:15pm
Local: Bornstein Amphitheater (Main Pike)
Speaker: Hedvig Hricak, MD
Chair, Department of Radiology
Memorial Sloan-Kettering Cancer Institute New York, NY
February 9th - Department of Medicine Seminar, Speaker: Toshio Suda, MD, PhD, Title: Glycolytic Metabolism of Stem Cells, Time: 2:00 PM, Location: CLS Conference Room 421
Department of Medicine Seminar, Speaker: Hideyuki Saya, MD, PhD, Title: Roles of CD44 in EMT and Cancer Stem Cells, Time: 2:30 PM, Location: CLS Conference Room 421
Dana-Farber/Harvard Cancer Center
A Comprehensive Cancer CenterDesignated by the National Cancer Institute